OraSure Technologies | OSUR - Ebitda



金融业
股票价格
USD
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 264.2M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


Ebitda 更改 日
Agilent USD 577M 77M 2026-06
AngioDynamics USD 5.94M 3.78M 2025-09
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Bio Techne USD 115.94M 763K 2026-06
Bio-Rad Laboratories USD 595.3M 1.23B 2026-06
Bruker USD 143.2M 33.2M 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Danaher USD 1.84B 81M 2026-06
Dentsply International USD 190M 61M 2026-06
Dexcom USD 364.5M 57.7M 2026-03
Illumina USD 330M 80M 2026-06
Integra LifeSciences USD 78.41M 2.23M 2026-06
Intuitive Surgical USD 1.06B 29.9M 2026-03
IQVIA Holdings USD 994M 62M 2026-06
Mesa Laboratories USD 9.58M 1.47M 2024-09
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Quidel USD 129.3M 20.6M 2026-06
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 228.18M 44.73M 2026-06
STAAR Surgical USD 20M 387K 2026-06
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Trinity Biotech USD -9.6M 7.64M 2024-12
Waters USD 712M 545M 2026-06